Cibc Private Wealth Group, LLC Silverback Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $50.1 Billion
- Q1 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 20,000 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SBTX
# of Institutions
117Shares Held
47.9MCall Options Held
442KPut Options Held
42K-
Deerfield Management Company, L.P. (Series C) New York, NY11.1MShares$00.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA9.24MShares$00.0% of portfolio
-
Sr One Capital Management, LP4.01MShares$00.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.95MShares$00.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$00.0% of portfolio
About Silverback Therapeutics, Inc.
- Ticker SBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,473,800
- Description
- Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...